id	keyword
dpc-6169	omalizumab
dpc-6169	patients
dpc-6169	response
dpc-6169	treatment
dpc-6169	disease
dpc-6169	age
dpc-6169	duration
dpc-6169	urticaria
dpc-6169	uas7
dpc-6169	baseline